The success of a primary percutaneous intervention (PCI) in the setting of ST elevation
myocardial infarction depends on the functional and structural integrity of coronary …

Percutaneous coronary intervention (PCI) is effective in opening the infarct related artery
and restoring thrombolysis in myocardial infarction flow 3 (TIMI-flow 3) in large majority of ST …

Heart failure is a chronic disease with high morbidity and mortality, which represents a
growing challenge in medicine. A major risk factor for heart failure with reduced ejection …

Ischemic heart disease is a leading cause of death worldwide. After the onset of myocardial
infarction, many pathological changes take place and progress the disease towards heart …

Background—Liraglutide, a glucagon-like peptide-1 analog, was reported to reduce
reperfusion injury in mice. We planned to evaluate the effects of liraglutide on reperfusion …

Background and Purpose—Microthrombi originating from disintegrated clots or formed in
situ may account for the poor clinical improvement of acute ischemic stroke after …

Background The 'no-reflow'phenomenon after a percutaneous coronary intervention (PCI) in
patients with acute ST-segment elevation myocardial infarction (STEMI) is a strong predictor …

Background—The aim of this study was to assess whether deferred stenting (DS) reduces
infarct size and microvascular obstruction (MVO) compared with immediate stenting (IS) in …

Despite successful restoration of epicardial coronary blood flow, a significant proportion of
patients with ST-elevation myocardial infarction suffer from an impairment of the …

Atorvastatin (ATV) has an important pro-survival role in cardiomyocytes after acute
myocardial infarction (AMI). The objectives of this study were to: 1) determine whether ATV …